The end of the era of cheap money, characterized by low-interest rates and easy access to credit, has significant implications for businesses seeking funding. As borrowing costs rise and credit becomes more difficult to access, companies may need to explore alternative funding sources or find ways to make their operations more efficient.
Investors are increasingly looking for companies with strong environmental, social, and governance (ESG) profiles, as they believe that these companies are more likely to be successful in the long run.
Companies with strong ESG profiles are more attractive to top talent, have strong relationships with stakeholders, and can better navigate regulatory challenges and potentially secure funding in this new economic environment by focusing on (ESG) issues.
Extracellular vesicles or exosome-based products and technologies are a promising area of research and development in the biotech industry, with many startups and more mature companies working to harness the potential of exosomes for a variety of therapeutic and diagnostic applications.
Download our white paper on how implementing the ESG framework can boost a company’s chances of securing investment and the long-term survival of the company:
INSIGHTS01 (pdf, new tab)
If you need ESG review or interested to know more, let us know: [email protected]
